Welzel et al [37] analyzed the relationship between variants in the IFN-α pathway and a sustained virologic response (SVR) among participants in the hepatitis C antiviral long-term treatment against the cirrhosis (HALT-C) trial. This evidence concerns the gene IFNA1 and Cirrhosis.